Market Overview

Research and Markets: Intestinal Cancer - Pipeline Review, H2 2012 Includes a Snapshot of the Global Therapeutic Scenario for Intestinal Cancer

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/9gp8mx/intestinal_cancer) has announced the addition of Global Markets Direct's new report "Intestinal Cancer - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Intestinal Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Intestinal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Intestinal Cancer. Intestinal Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Companies Mentioned:

- Johnson & Johnson

- F. Hoffmann-La Roche Ltd.

- Kyowa Hakko Kirin Co., Ltd.

- Abbott Laboratories

- Amgen Inc.

- AstraZeneca PLC

- Eli Lilly and Company

- Viralytics Ltd.

- GlaxoSmithKline plc

- Bioniche Life Sciences, Inc.

- Tekmira Pharmaceuticals Corp.

- Gilead Sciences, Inc.

- Daiichi Sankyo Company, Ltd

- AbGenomics International, Inc.

- Oxford BioMedica plc

- YM BioSciences Inc.

- Celltrion, Inc.

- Prolexys Pharmaceuticals, Inc.

- Bio-Path Holdings, Inc.

- BioSante Pharmaceuticals, Inc.

- Histogen, Inc.

- Novartis AG

- Geistlich Pharma AG

- Aphios Corporation

- Astellas Pharma Inc.

- Chong Kun Dang Pharmaceutical

- Eisai Co., Ltd.

- Nippon Kayaku Co., Ltd.

- Taiho Pharmaceutical Co., Ltd.

- Teva Pharmaceutical Industries Limited

- Yakult Honsha Co., Ltd.

- Enzon Pharmaceuticals, Inc.

- Alfacell Corporation

- Bayer AG

- 4SC AG

- Neogenix Oncology Corporation

- Alchemia Limited

- EntreMed, Inc.

- Celldex Therapeutics, Inc.

- Enzo Biochem, Inc.

For more information visit http://www.researchandmarkets.com/research/9gp8mx/intestinal_cancer

Source: Global Markets Direct

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

 

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters